Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0001493152-26-009042 0002057383 XXXXXXXX LIVE 3 Common Stock, Par Value $0.001 Per Share 08/04/2026 false 0000840715 18506U203 CLEARONE INC 7533 S Center View Ct. #5311 West Jordan UT 84084 Benasz Hansotia 646-885-6532 c/o Sichenzia Ross Ference Carmel LLP 1185 Avenue of the Americas, 26th Floor New York NY 10036 0002057383 N First Finance Ltd. WC N X1 1641162.00 0.00 1641162.00 0.00 1641162.00 N 61.3 CO 0001145688 N Hromyk Andrew OO N Z4 0.00 1641162.00 0.00 1641162.00 1641162.00 N 61.3 IN Common Stock, Par Value $0.001 Per Share CLEARONE INC 7533 S Center View Ct. #5311 West Jordan UT 84084 On March 2, 2026, First Finance Ltd. entered into a Securities Purchase Agreement with ClearOne, Inc. (the "Issuer") pursuant to which First Finance Ltd. agreed to acquire, for a total purchase price of $1,750,000, (i) 437,500 shares of the Issuer's common stock and (ii) a warrant to purchase up to 437,500 shares of common stock (the "Warrant"). The transaction closed on or around March 6, 2026. On August 4, 2026, pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, CLRO Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), Cortigent, Inc. ("Cortigent"), and Vivani Medical, Inc. ("Vivani"), pursuant to which Merger Sub will merge with and into Cortigent, with Cortigent surviving as a wholly-owned subsidiary of the Issuer, First Finance Ltd. entered into a Warrant Cancellation Agreement with the Issuer pursuant to which First Finance Ltd. surrendered and cancelled the Warrant in its entirety for no consideration. As a result of the Warrant Cancellation Agreement, First Finance Ltd. no longer holds any derivative securities of the Issuer. This Amendment No. 3 is being filed to report the cancellation of the Warrant in its entirety for no consideration. On July 1, 2026, the Issuer entered into the Merger Agreement, pursuant to which Merger Sub will merge with and into Cortigent, with Cortigent surviving as a wholly-owned subsidiary of the Issuer. As consideration for all of the issued and outstanding shares of common stock of Cortigent, Vivani will receive 12,500,000 shares of the Issuer's common stock. The Merger Agreement was disclosed by the Issuer in a Current Report on Form 8-K filed with the SEC on July 6, 2026. As the majority beneficial owner of the Issuer's common stock, the Reporting Persons are supportive of the Merger Agreement. Except as described herein, the Reporting Persons have no plans or proposals which relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to change their plans and intentions at any time, as they deem appropriate. First Finance Ltd. directly owns 1,641,162 shares of the Issuer's common stock. Based upon an aggregate of 2,675,412 shares of common stock issued and outstanding as of August 5, 2026, according to information provided by the Issuer, the shares of the Issuer's common stock owned by First Finance Ltd. constitute approximately 61.3% of the common stock of the Issuer as calculated in accordance with Rule 13d-3(d)(1). Mr. Hromyk beneficially owns 1,641,162 shares of the Issuer's common stock, resulting from Mr. Hromyk's pecuniary interest in First Finance Ltd., constituting approximately 61.3% of the common stock of the Issuer. Following the cancellation of the Warrant on August 4, 2026, neither First Finance Ltd. nor Mr. Hromyk holds any derivative securities of the Issuer. First Finance Ltd. beneficially owns 1,641,162 shares of the Issuer's common stock. Mr. Hromyk beneficially owns 1,641,162 shares of the Issuer's common stock, resulting from Mr. Hromyk's pecuniary interest in First Finance Ltd. Neither First Finance Ltd. nor Mr. Hromyk holds any right to acquire additional shares of the Issuer's common stock. On August 4, 2026, pursuant to the Merger Agreement, First Finance Ltd. entered into the Warrant Cancellation Agreement with the Issuer as described in Item 3 above. Except as set forth herein, the Reporting Persons have not effected any other transactions in any securities of the Issuer in the past 60 days. N/A N/A On August 4, 2026, pursuant to the Merger Agreement, First Finance Ltd. entered into the Warrant Cancellation Agreement with the Issuer, pursuant to which First Finance Ltd. surrendered and cancelled the Warrant to purchase up to 437,500 shares of the Issuer's common stock for no consideration. A copy of the Warrant Cancellation Agreement is filed as an exhibit hereto. 99.1 - Warrant Cancellation Agreement, dated as of August 4, 2026, by and between ClearOne, Inc. and First Finance Ltd. (incorporated by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the SEC on August 5, 2026). 99.2 - Joint Filing Agreement, dated as of November 26, 2025, by and between Andrew Hromyk and First Finance Ltd. (previously filed as an exhibit to Amendment No. 1). First Finance Ltd. /s/ Andrew Hromyk Andrew Hromyk, Principal 08/06/2026 Hromyk Andrew /s/ Andrew Hromyk Andrew Hromyk, Self 08/06/2026